Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P41
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -8.50% |
| Q3 2025 | -15.01% |
| Q2 2025 | 30.52% |
| Q1 2025 | 16.31% |
| Q4 2024 | -58.48% |
| Q3 2024 | -16.34% |
| Q2 2024 | 27.26% |
| Q1 2024 | -37.52% |
| Q4 2023 | -17.27% |
| Q3 2023 | 7.09% |
| Q2 2023 | 30.17% |
| Q1 2023 | -44.22% |
| Q4 2022 | 7.16% |
| Q3 2022 | 6.26% |
| Q2 2022 | 24.25% |
| Q1 2022 | -13.48% |
| Q4 2021 | -4.03% |
| Q3 2021 | 27.55% |
| Q2 2021 | 3.46% |
| Q1 2021 | -143.72% |
| Q4 2020 | 31.95% |
| Q3 2020 | -2.04% |
| Q2 2020 | 34.33% |
| Q1 2020 | -9.08% |
| Q4 2019 | -14.62% |
| Q3 2019 | 2.01% |
| Q2 2019 | 15.09% |
| Q1 2019 | -39.96% |
| Q4 2018 | -12.33% |
| Q3 2018 | 2.58% |
| Q2 2018 | 31.54% |
| Q1 2018 | -32.61% |
| Q4 2017 | 5.02% |
| Q3 2017 | -32.84% |
| Q2 2017 | 19.29% |
| Q1 2017 | -41.80% |
| Q4 2016 | 0.02% |
| Q3 2016 | -133.82% |
| Q2 2016 | 819.94% |
| Q1 2016 | 34.15% |